ブース番号5P-07
カテゴリーアウトソーシング
Gradiant Bioconvergence, Inc.
小間番号:5P-07
カテゴリー:アウトソーシング
jeyoungryu@gradiantbio.com
+82-2-6483-1400
住所: 4th floor, 558, Songpa-daero, Songpa-gu, Seoul, Korea, 05510
https://www.gradiantbio.com
Gradiant Bioconvergence is the world's first organoid company with the world's largest cancer patient organoid bank, we carry out global businesses such as AI-based anticancer target discovery, biomarker screening, and disease modeling.
Our patient-derived organoids are established with genome analysis and drug reactivity. Our proprietary AI algorithm integrates multifaceted information to derive targets in an unprecedented and innovative way.
Our patient-derived organoids are established with genome analysis and drug reactivity. Our proprietary AI algorithm integrates multifaceted information to derive targets in an unprecedented and innovative way.
企業情報
住所 | 4th floor, 558, Songpa-daero, Songpa-gu, Seoul, Korea, 05510 |
---|---|
TEL | +82-2-6483-1400 |
FAX | +82-2-6483-1500 |
URL | https://www.gradiantbio.com |
jeyoungryu@gradiantbio.com |
出展品目 |
Cancer Patient-Derived Organoid (w/ Clinical & NGS data) Alzheimer's disease Patient-Derived Brain Organoid Brain Organoid Disease Modeling Collaborative Research Drug Screening Service Growth Factors (Noggin, RSPO1/3, FGF7/10) |
---|